PRESS RELEASES

Found 263 Results
Page 1 of 27


Onxeo Has Applied for Admission to Trading on Nasdaq First North Growth Market Denmark and Delisting from Nasdaq Main Market Copenhagen


Paris (France), November 27, 2020 – 6 pm CET – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the […]

11/27/2020


Onxeo Announces Completion of Patient Enrollment in DRIIV-1b Study and Positive Interim Results


The last patient was treated with AsiDNA™ in combination with carboplatin and paclitaxel in this Phase 1b study in patients […]

Tags:

11/09/2020


Onxeo Receives Notice of Intent to Grant a New Patent Enhancing the Protection in Europe of AsiDNA™ Combined with PARP Inhibitors


This new patent protects the method of use of AsiDNA™ in combination with PARP inhibitors in the treatment of HR-proficient […]

Tags:

10/22/2020


Onxeo Announces Enrollment of First Patient in Phase Ib/II Study Revocan


Revocan is designed to evaluate the abrogation by AsiDNA™ of tumor resistance to a PARP inhibitor in relapsed ovarian cancer […]

Tags:

10/21/2020


Publication of the 2020 Half-Yearly Financial Report


Paris (France), September 29, 2020 – 6.00 pm CEST – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO – FR0010095596), (“Onxeo” […]

09/29/2020


Onxeo reports its financial results for the first half of 2020 and provides an update on its activities


The cash position of €19.6 million, which was strengthened in the first half of the year by two strategic transactions, […]

09/17/2020


Onxeo to Attend Key Investor Conferences and Events in the Second Half of 2020


Paris (France), September 8, 2020 – 7:00 am CEST – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the […]

09/08/2020


Onxeo Receives Notice of Allowance from USPTO for New Patent Strengthening Protection of AsiDNA™ via Systemic Administration in the United States


This new patent will add to the protection of AsiDNA™ and its related compounds for their use via systemic administration […]

Tags:

09/03/2020


Page 1 of 27